<DOC>
	<DOCNO>NCT02755935</DOCNO>
	<brief_summary>To evaluate performance outcome patient implant Cochlear Nucleus CI532 electrode array .</brief_summary>
	<brief_title>CI532 - Early Experience Study</brief_title>
	<detailed_description>To compare speech perception audiometric outcomes patient implanted Cochlear Nucleus CI532 electrode array 3 month postactivation best preoperative hearing status .</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Hearing Loss , Sensorineural</mesh_term>
	<mesh_term>Hearing Loss , Bilateral</mesh_term>
	<criteria>Medical audiological candidate CI532 cochlear implant per commercially approve , age appropriate , FDA indication Postlinguistically deafen Ability complete age appropriate test Previous cochlear implantation ear implant Prelinguistically deafen ( onset hearing loss less two year age ) Ossification cochlear anomaly might prevent complete insertion electrode array Diagnosis retrocochlear pathology Diagnosis auditory neuropathy Unrealistic expectation part subject regard possible benefit , risk , limitation inherent surgical procedure use prosthetic device Unwillingness inability comply investigational requirement Additional cognitive handicap would prevent participation study requirement</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>